Solvi Rognvaldsson

Solvi Rognvaldsson

Auto-generated profile, based on publicly available information

Solvi Rognvaldsson

DeCODE genetics/AMGEN Inc., Reykjavik, Iceland

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2021 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
EFEgil Ferkingstad
Egil Ferkingstad
PSPatrick Sulem
Patrick Sulem
BABjarni A. Atlason
Bjarni A. Atlason
GSGardar Sveinbjornsson
Gardar Sveinbjornsson
MMMagnus I. Magnusson
Magnus I. Magnusson
KSKari Stefansson
Kari Stefansson

5 December 2021 in Environmetrics
Verified
Journal Article
Closed access
PDF file
BHBirgir Hrafnkelsson
Birgir Hrafnkelsson
HSHelgi Sigurdarson
Helgi Sigurdarson
SRSölvi Rögnvaldsson
Sölvi Rögnvaldsson
AJAxel Örn Jansson
Axel Örn Jansson
RVRafael Daníel Vias
Rafael Daníel Vias
SGSigurdur M. Gardarsson
Sigurdur M. Gardarsson

7 October 2021 in Communications Biology
Verified
Journal Article
Open access
PDF file
ASAstros Th. Skuladottir
Astros Th. Skuladottir
GBGyda Bjornsdottir
Gyda Bjornsdottir
MNMuhammad Sulaman Nawaz
Muhammad Sulaman Nawaz
HPHannes Petersen
Hannes Petersen
SRSolvi Rognvaldsson
Solvi Rognvaldsson
KSKari Stefansson
Kari Stefansson
Vertigo is the leading symptom of vestibular disorders and a major risk factor for falls. In a genome-wide association study of vertigo (Ncases = 48,072, Ncontrols = 894,541), we uncovered an association with six common sequence variants in individuals of European ancestry, including missense variants in ZNF91, OTOG, OTOGL, and TECTA, and a cis-eQTL for ARMC9. The association of variants in ZNF91, OTOGL, and OTOP1 was driven by an association with benign paroxysmal positional vertigo. Using previous reports of sequence variants associating with age-related hearing impairment and motion sickness, we found eight additional variants that associate with vertigo. Although disorders of the auditory and the vestibular system may co-occur, none of the six genome-wide significant vertigo variants were associated with hearing loss and only one was associated with age-related hearing impairment. Our results uncovered sequence variants associating with vertigo in a genome-wide association study and implicated genes with known roles in inner ear development, maintenance, and disease.

18 February 2021 in Cancer Research
Verified
Journal Article
Open access
PDF file
TOThorhildur Olafsdottir
Thorhildur Olafsdottir
SSSimon N. Stacey
Simon N. Stacey
GSGardar Sveinbjornsson
Gardar Sveinbjornsson
GTGudmar Thorleifsson
Gudmar Thorleifsson
KNKristjan Norland
Kristjan Norland
KSKari Stefansson
Kari Stefansson
The success of genome-wide association studies (GWAS) in identifying common, low-penetrance variant-cancer associations for the past decade is undisputed. However, discovering additional high-penetrance cancer mutations in unknown cancer predisposing genes requires detection of variant-cancer association of ultra-rare coding variants. Consequently, large-scale next-generation sequence data with associated phenotype information are needed. Here, we used genotype data on 166,281 Icelanders, of which, 49,708 were whole-genome sequenced and 408,595 individuals from the UK Biobank, of which, 41,147 were whole-exome sequenced, to test for association between loss-of-function burden in autosomal genes and basal cell carcinoma (BCC), the most common cancer in Caucasians. A total of 25,205 BCC cases and 683,058 controls were tested. Rare germline loss-of-function variants in PTPN14 conferred substantial risks of BCC (OR, 8.0; P = 1.9 × 10−12), with a quarter of carriers getting BCC before age 70 and over half in their lifetime. Furthermore, common variants at the PTPN14 locus were associated with BCC, suggesting PTPN14 as a new, high-impact BCC predisposition gene. A follow-up investigation of 24 cancers and three benign tumor types showed that PTPN14 loss-of-function variants are associated with high risk of cervical cancer (OR, 12.7, P = 1.6 × 10−4) and low age at diagnosis. Our findings, using power-increasing methods with high-quality rare variant genotypes, highlight future prospects for new discoveries on carcinogenesis. Significance: This study identifies the tumor-suppressor gene PTPN14 as a high-impact BCC predisposition gene and indicates that inactivation of PTPN14 by germline sequence variants may also lead to increased risk of cervical cancer.

9 June 2023 in Science Advances
Verified
Journal Article
Open access
RGRosa S. Gisladottir
Rosa S. Gisladottir
AHAgnar Helgason
Agnar Helgason
BHBjarni V. Halldorsson
Bjarni V. Halldorsson
HHHannes Helgason
Hannes Helgason
MBMichal Borsky
Michal Borsky
KSKari Stefansson
Kari Stefansson
The genetic basis of the human vocal system is largely unknown, as are the sequence variants that give rise to individual differences in voice and speech. Here, we couple data on diversity in the sequence of the genome with voice and vowel acoustics in speech recordings from 12,901 Icelanders. We show how voice pitch and vowel acoustics vary across the life span and correlate with anthropometric, physiological, and cognitive traits. We found that voice pitch and vowel acoustics have a heritable component and discovered correlated common variants in ABCC9 that associate with voice pitch. The ABCC9 variants also associate with adrenal gene expression and cardiovascular traits. By showing that voice and vowel acoustics are influenced by genetics, we have taken important steps toward understanding the genetics and evolution of the human vocal system.

27 September 2021 in Communications Biology
Verified
Journal Article
Open access
PDF file
EMEvgenia Mikaelsdottir
Evgenia Mikaelsdottir
GTGudmar Thorleifsson
Gudmar Thorleifsson
LSLilja Stefansdottir
Lilja Stefansdottir
GHGisli Halldorsson
Gisli Halldorsson
JSJon K. Sigurdsson
Jon K. Sigurdsson
KSKari Stefansson
Kari Stefansson
Platelets play an important role in hemostasis and other aspects of vascular biology. We conducted a meta-analysis of platelet count GWAS using data on 536,974 Europeans and identified 577 independent associations. To search for mechanisms through which these variants affect platelets, we applied cis-expression quantitative trait locus, DEPICT and IPA analyses and assessed genetic sharing between platelet count and various traits using polygenic risk scoring. We found genetic sharing between platelet count and counts of other blood cells (except red blood cells), in addition to several other quantitative traits, including markers of cardiovascular, liver and kidney functions, height, and weight. Platelet count polygenic risk score was predictive of myeloproliferative neoplasms, rheumatoid arthritis, ankylosing spondylitis, hypertension, and benign prostate hyperplasia. Taken together, these results advance understanding of diverse aspects of platelet biology and how they affect biological processes in health and disease.